local_hospital

Haelan Care 4 Medical Center Ltd.

Address
Bulevard Vladislav Varnenchik 267, 9000 Varna, Bulgaria

Cardiovascular Diseases

The site is conducting trials focused on cardiovascular disease, including patients with established cardiovascular disease, those at high cardiovascular risk, and individuals with hypertension. The main goal is to assess whether a new RNA‑interference therapy can lower the incidence of heart attacks, strokes, and heart‑failure events.

  • Evaluation of cardiovascular event risk reduction
  • Improved blood‑pressure management in resistant hypertension
  • Assessment of novel RNAi‑based treatment safety

Research is carried out at Haelan Care 4 Medical Center Ltd. in Varna, Bulgaria, contributing to European efforts to advance heart and vascular health.

Nervous System Diseases

Studies at the center target myasthenia gravis, both generalized and ocular forms, aiming to determine the safety and therapeutic benefit of an investigational antibody‑modulating agent. Participants include those with AChR antibody‑positive and -negative disease.

  • Safety and tolerability profiling of novel immunotherapies
  • Efficacy assessment in AChR antibody‑positive myasthenia gravis
  • Exploration of treatments for ocular myasthenia gravis

The trials are part of the research portfolio of Haelan Care 4 Medical Center Ltd., enhancing therapeutic options for neurological disorders in the region.

Site Overview

assignment
3
connected trials
corporate_fare
3
sponsors
science
22
IMPs

Activity Indicator

Last 6 months

1
Trials started
-50% vs previous period.
2
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_downDeclining-50%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 2 of 3 therapeutic areas and 15 of 22 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
3
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
3
Outperforms 46% of sites
public
Therapeutic diversity
3areas
Outperforms 64% of sites
groups
Sponsor diversity
3sponsors
Outperforms 53% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Haelan Care 4 Medical Center Ltd.

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Phase 1b/2 Study of IM-101 in Adult Participants with Generalized and Ocular Myasthenia GravisImmunabs Inc.Phase IRecruitingJun 2026

IMP list

lock Showing 1 of 22 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Depemokimab1Unknown2026-07-312026-07-31

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.